𝔖 Bobbio Scriptorium
✦   LIBER   ✦

N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines

✍ Scribed by Changping Zou; Yongli Guan; Changchun Zou; Jian Wang; Li-E. Wang; Monica Liebert; H.Barton Grossman; Qingyi Wei


Book ID
117467257
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
160 KB
Volume
180
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Upregulation of GADD153 expression in th
✍ Yuhe Xia; Nai-Sum Wong; Wang-Fun Fong; Henk Tideman πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 322 KB

## Abstract The molecular basis for the pharmacologic effects of __N__‐(4‐hydroxyphenyl)retinamide (4HPR) was investigated by studying the gene(s) that this compound may upregulate in cultured human epithelial tumor cells. Treatment of the cultured human nasopharyngeal carcinoma‐derived cells (CNE3

Is growth inhibition and induction of ap
✍ Carsten-Henning Ohlmann; Christine Jung; Gabriele Jaques πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 303 KB πŸ‘ 1 views

## Abstract The synthetic retinoid fenretinide [N‐(4‐hydroxyphenyl)retinamide, 4‐HPR] has demonstrated growth inhibition and induction of apoptosis of various malignant cells, including lung cancer cell lines. 4‐HPR is now being investigated in several clinical trials. In our study, we show that 4‐

N-(4-hydroxyphenyl)retinamide induces ap
✍ William Samuel; R. Krishnan Kutty; Sahrudaya Nagineni; Camasamudram Vijayasarath πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 418 KB

## Abstract __N__‐(4‐hydroxyphenyl)retinamide (4HPR, fenretinide), a retinoic acid (RA) derivative and a potential cancer preventive agent, is known to exert its chemotherapeutic effects in cancer cells through induction of apoptosis. Earlier work from our laboratory has shown that relatively low c